Citadel Advisors’s EUDA Health Holdings EUDA Stock Holding History

Citadel Advisors’s Portfolio EUDA Stock Details EUDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,232	Closed	-$77.7K	–	13019
2025 Q3	$77.7K	Buy	2,232 +816	+58%	+$39.6K	﹤0.01%	11992
2025 Q2	$99.9K	Buy	+1,416	New	+$105K	﹤0.01%	11346
2024 Q4	–	Sell	-1,691	Closed	-$133K	–	14731
2024 Q3	$133K	Buy	1,691 +28	+2%	+$2.21K	﹤0.01%	10714
2024 Q2	$102K	Sell	1,663 -1,482	-47%	-$66.5K	﹤0.01%	10887
2024 Q1	$115K	Sell	3,145 -4,015	-56%	-$120K	﹤0.01%	11162
2023 Q4	$205K	Sell	7,160 -717	-9%	-$17.8K	﹤0.01%	9904
2023 Q3	$250K	Buy	7,877 +5,433	+222%	+$103K	﹤0.01%	9495
2023 Q2	$37.2K	Buy	+2,444	New	+$67.2K	﹤0.01%	12128

Other funds holding EUDA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Citadel Advisors's EUDA Position: Q4 2025 in Review

Citadel Advisors sold out of EUDA Health Holdings (EUDA) in Q4 2025, closing a stake of 2,232 shares — an estimated $77.7K sold.

Citadel Advisors first reported a position in EUDA in Q2 2023 and held it in 8 quarters. The position peaked at $250K in Q3 2023. 4 funds tracked by Wall St. Rank hold EUDA as of Q4 2025.

Citadel Advisors reported no remaining EUDA Health Holdings position as of Q4 2025 after selling out during the quarter.
Citadel Advisors sold 2,232 EUDA Health Holdings shares in Q4 2025, an estimated $77.7K.
Citadel Advisors first reported a position in EUDA Health Holdings in Q2 2023 and held it in 8 quarters.
Citadel Advisors's EUDA Health Holdings position peaked at $250K in Q3 2023.
4 funds tracked by Wall St. Rank held EUDA Health Holdings as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.